261 studies found for:    "Tetanus"
Show Display Options
Rank Status Study
21 Completed
Has Results
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed
22 Recruiting Post Marketing Surveillance for ADACEL™ in South Korea
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined
23 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
24 Completed
Has Results
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
25 Completed
Has Results
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed
26 Recruiting Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301);   Biological: Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)
27 Completed Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: Shan 5;   Biological: Easy Five
28 Completed Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Polio;   Haemophilus Influenzae Type b
Interventions: Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine);   Biological: Pentacel: DTaP-IPV/Hib
29 Completed
Has Results
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
30 Completed
Has Results
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
Conditions: Meningitis;   Meningococcemia;   Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
31 Completed
Has Results
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Intervention: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
32 Completed Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
33 Completed
Has Results
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio;   Haemophilus Infection
Intervention: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)
34 Completed
Has Results
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®)
35 Recruiting Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
Conditions: Acellular Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Other: Infanrix-IPV data collection
36 Completed Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Conditions: Diphtheria, Tetanus, Pertussis, Poliomyelitis & Haemophilus Influenzae Type b Disease;   Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines
Intervention: Biological: GSK Biologicals' combined DTPa-IPV/Hib vaccine
37 Completed Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DT5aP-IPV-Hib 5-component Pertussis vaccine;   Biological: Infanrix® -IPV+Hib
38 Completed Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults
Conditions: Diphtheria;   Pertussis;   Tetanus
Interventions: Biological: GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine;   Biological: GSK Biologicals' acellular pertussis vaccine;   Biological: Commonwealth Serum Laboratories' combined diphtheria and tetanus vaccine
39 Completed Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Tetanus
Interventions: Biological: GSK Biologicals' reduced antigen diphtheria and tetanus toxoids and acellular pertussis- inactivated poliovirus vaccine;   Biological: Boostrix™;   Biological: GSK Biologicals' IPV vaccine;   Biological: Revaxis®
40 Completed
Has Results
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years